Schizophrenia. Environmental factors

Содержание

Слайд 2


Слайд 3

Environmental factors

Environmental factors

Слайд 4

Age of onset and peak of mental disorders Nat Rev Neurosci (2), & 2008

Age of onset and peak of mental disorders

Nat Rev Neurosci (2),

& 2008
Слайд 5

Слайд 6

Schizophrenia: inheritance

Schizophrenia: inheritance

Слайд 7

Manhattan plot showing schizophrenia associations S Ripke et al. Nature 1-7 (2014)

Manhattan plot showing schizophrenia associations

S Ripke et al. Nature 1-7

(2014)
Слайд 8

Subdivision of Symptoms into Three Dimensions Psychotic Delusions Hallucinations Disorganized Disorganized

Subdivision of Symptoms into Three Dimensions

Psychotic
Delusions
Hallucinations
Disorganized
Disorganized speech
Disorganized behavior
Inappropriate affect
Negative
Poverty of speech
Avolition
Affective

Blunting
Anhedonia
Слайд 9

Types of Hallucinations Auditory Visual Tactile Olfactory

Types of Hallucinations

Auditory
Visual
Tactile
Olfactory

Слайд 10

Types of Delusions Persecutory Grandiose Religious Jealous Somatic

Types of Delusions

Persecutory
Grandiose
Religious
Jealous
Somatic

Слайд 11

DSM-5 Criteria for Schizophrenia: The Basics Characteristic symptoms for one month

DSM-5 Criteria for Schizophrenia: The Basics

Characteristic symptoms for one month
Social/Occupational Dysfunction
Overall

Duration > 6 months
Not attributable to mood disorder
Not attributable to substance use or general medical condition
Слайд 12

Differential Diagnosis Mood Disorders Nonpsychotic personality disorders Substance-induced psychotic disorders Psychotic

Differential Diagnosis

Mood Disorders
Nonpsychotic personality disorders
Substance-induced psychotic disorders
Psychotic disorders due to a

general medical condition (i.e., “organic” disorders)
Слайд 13

Drugs That May Induce Psychosis Amphetamines Marijuana Hallucinogens Cocaine Cannabis

Drugs That May Induce Psychosis

Amphetamines
Marijuana
Hallucinogens
Cocaine
Cannabis

Слайд 14

Medical Conditions That May Present with Psychosis Temporal lobe epilepsy Tumor

Medical Conditions That May Present with Psychosis

Temporal lobe epilepsy
Tumor
Stroke
Trauma
Endocrine/metabolic abnormalities
Infections
Multiple Sclerosis
Autoimmune

diseases
Слайд 15

The Dopamine Hypothesis Psychosis (schizophrenia?) is due to excessive dopaminergic tone

The Dopamine Hypothesis

Psychosis (schizophrenia?) is due to excessive dopaminergic tone
Psychotic symptoms

are relieved by blockade of dopamine receptors with neuroleptic medications
Слайд 16

Copyright restrictions may apply. Howes, O. D. et al. Arch Gen

Copyright restrictions may apply.

Howes, O. D. et al. Arch Gen Psychiatry

2012;0:archgenpsychiatry.2012.169v1-11.

Schematic diagram summarizing the findings from our meta-analyses of dopamine function in schizophrenia

Слайд 17

Слайд 18

Слайд 19

Brain Regions Showing Replicable Neuropathological Abnormalities Temporolimbic regions Thalamus Prefrontal cortex

Brain Regions Showing Replicable Neuropathological Abnormalities

Temporolimbic regions
Thalamus
Prefrontal cortex

Слайд 20

Neuropil in Frontal Cortex

Neuropil in Frontal Cortex

Слайд 21

Слайд 22

Criterion A: Characteristic Symptoms At least two of the following, each

Criterion A: Characteristic Symptoms

At least two of the following, each present

for a significant portion of time during a one month period (or less if successfully treated):
(1) delusions
(2) hallucinations
(3) disorganized speech (e.g., frequent derailment or incoherence)
(4) grossly disorganized or catatonic behavior
(5) negative symptoms, I.e., affective flattening, alogia, or avolition
Слайд 23

Gender Differences Males have an earlier age at onset, a poorer

Gender Differences

Males have an earlier age at onset, a poorer premorbid

history, more negative symptoms, a poorer outcome, and more prominent brain abnormalities as measured in neuroimaging studies
Women have more prominent affective symptoms and a better outcome
Слайд 24

Important Epidemiolgical Observations Prevalence is not highly variable over time or

Important Epidemiolgical Observations

Prevalence is not highly variable over time or over

geographical areas
Found in all cultures
More common and/or severe in males than females
Persists in the population despite decreased fertility
Слайд 25

Bleuler’s Fundamental Symptoms Associations Affective Blunting Avolition Autism Ambivalence Attention

Bleuler’s Fundamental Symptoms

Associations
Affective Blunting
Avolition
Autism
Ambivalence
Attention

Слайд 26

Schneider: The Psychotic Experience Interested in pathognomonic symptoms “First Rank Symptoms”

Schneider: The Psychotic Experience

Interested in pathognomonic symptoms
“First Rank Symptoms” (FRS)
E.g., voices

commenting
Voices arguing
Thought insertion
Involve a loss of the sense of autonomy of self, or “ego boundaries”
Слайд 27

Characteristic Symptoms Schneider: specific types of delusions and hallucinations Bleuler: fragmented

Characteristic Symptoms

Schneider: specific types of delusions and hallucinations
Bleuler: fragmented thinking, inability

to relate to external world
Kraepelin: emotional dullness, avolition, loss of inner unity
Слайд 28

Criterion B: Social/Occupational Dysfunction For a significant portion of the time

Criterion B: Social/Occupational Dysfunction

For a significant portion of the time since

the onset of the disturbance, one or more major areas of functioning such as work, interpersonal relations or self-care is markedly below the level achieved prior to the onset
OR when the onset is in childhood or adolescence, failure to achieve expected level of interpersonal, academic, or occupational achievement
Слайд 29

Criterion C: Overall Duration Continuous signs of the disturbance persist for

Criterion C: Overall Duration

Continuous signs of the disturbance persist for at

least six months
This six-month period must include at least one month of symptoms that meet criterion A (i.e., active phase symptoms), and may include periods of prodromal or residual symptoms
During these prodromal or residual period, the signs of the disturbance may be manifested by only negative symptoms or two or more symptoms listed in criterion A present in an attenuated form (e.g. odd beliefs, unusual perceptual experiences)
Слайд 30

Criterion D: Schizoaffective and Mood Disorder Exclusion Schizoaffective Disorder and Mood

Criterion D: Schizoaffective and Mood Disorder Exclusion

Schizoaffective Disorder and Mood Disorder

with Psychotic Features have been ruled out because of either:
No major depressive or manic episodes have occurred concurrently with the active phase symptoms; or
If mood episodes have occurred during active phase symptoms, their total duration has been brief relative to the duration of the active and residual periods
Слайд 31

Criterion E: Substance / General Medical Condition Exclusion The disturbance is

Criterion E: Substance / General Medical Condition Exclusion

The disturbance is not

due to the direct effects of a substance (e.g., drugs of abuse, medication) or a general medical condition
Слайд 32

DSM 5: Categories of Psychosis Schizophreniform Disorder Schizophrenia Brief Psychotic Disorder

DSM 5: Categories of Psychosis

Schizophreniform Disorder
Schizophrenia
Brief Psychotic Disorder
Schizoaffective Disorder
Delusional Disorder
Shared Psychotic

Disorder
Psychotic Disorder due to a General Medical Condition
Substance-Induced Psychotic Disorder
Psychotic Disorder Not Otherwise Specified
Слайд 33

Poor Outcome: Predictors Prominent negative symptoms Early age of onset Insidious

Poor Outcome: Predictors

Prominent negative symptoms
Early age of onset
Insidious onset
Poor premorbid adjustment
Low

educational achievement
Low parental social class
Male gender
Слайд 34

Слайд 35

Lower Social Class in Schizophrenia Consistently observed in patients Lower social

Lower Social Class in Schizophrenia

Consistently observed in patients
Lower social class is

a result—not a cause—of the illness
Social class of parents does not differ from the general population
Lower social class is due to “downward drift,” not to social deprivation, poor nutrition, or inadequate access to health care
Слайд 36

Genetic Questions Is the disorder familial? Relative contributions of genes and

Genetic Questions

Is the disorder familial?
Relative contributions of genes and environment
Mode of

transmission
Location of gene
Function and products of gene
Role of the products in illness mechanisms
Слайд 37

Genetic Methods Family history studies Family studies Twin studies Adoption studies

Genetic Methods

Family history studies
Family studies
Twin studies
Adoption studies
Linkage and association studies, candidate

genes
Molecular genetics—functional genomics, proteomics
Слайд 38

Manhattan plot showing schizophrenia associations S Ripke et al. Nature 1-7 (2014)

Manhattan plot showing schizophrenia associations

S Ripke et al. Nature 1-7

(2014)
Слайд 39

Family History and Family Studies Provide evidence for a modest level

Family History and Family Studies

Provide evidence for a modest level of

familial transmission
Morbid risk for parents: 5.6%
Morbid risk for siblings: 10.1%
Morbid risk for offspring: 12.8%
Second degree relatives: 2.4-4.2%
Слайд 40

Possible Reasons for Lack of Measurable Abnormalities Problems in defining the

Possible Reasons for Lack of Measurable Abnormalities

Problems in defining the

phenotype
No single pathophysiology
Due to reversible neurochemical processes
Not accessible using traditional neuropathology tools
In areas where neuropathologists have not yet looked
Due to abnormalities in connectivity
Слайд 41

Hippocampal Atrophy in Schizophrenia Patients Controls

Hippocampal Atrophy in Schizophrenia

Patients

Controls

Слайд 42

Thalamic Nuclei

Thalamic Nuclei

Слайд 43

A Neurodevelopmental Disorder: Supporting Evidence from Neuropathology Absence of gliosis Abnormal

A Neurodevelopmental Disorder: Supporting Evidence from Neuropathology

Absence of gliosis
Abnormal cytoarchitecture
Visible markers

of neurodevelopmental abnormalities such as cavum septi pellucidi
Слайд 44

Classified Images Continuous Discrete

Classified Images

Continuous

Discrete

Слайд 45

MR Studies: Brain Abnormalities Decreased temporal lobe size Decreased frontal lobe

MR Studies: Brain Abnormalities

Decreased temporal lobe size
Decreased frontal lobe size
Decreased hippocampal

size
Decreased thalamic size
Gyral decreases (superior temporal gyrus, ventral frontal gyri)
General and regional decreases in gray matter volume
Слайд 46

A Neurodevelopmental Brain Disease Most brain abnormalities are present at onset:

A Neurodevelopmental Brain Disease

Most brain abnormalities are present at onset: e.g.,

decrease in total brain tissue
Occasional evidence of defects in neuronal migration: gray matter heterotopias
Midline abnormalities: cavum septi pellucidi, dysgenesis of the corpus callosum, ventricular enlargement
Слайд 47

Increased Blood Flow in Striatum due to Chronic Dopamine Blockade by Haloperidol

Increased Blood Flow in Striatum due to Chronic Dopamine Blockade by

Haloperidol
Слайд 48

Functional Imaging Tools Single Photon Emission Computed Tomography (SPECT) Positron Emission

Functional Imaging Tools

Single Photon Emission Computed Tomography (SPECT)
Positron Emission Tomography (PET)
Functional

Magnetic Resonance (fMR)
Слайд 49

Conclusions from PET Studies Schizophrenia is not a disease of a

Conclusions from PET Studies

Schizophrenia is not a disease of a single

brain region
Areas of abnormality vary depending on the task and the nature of current symptoms
Schizophrenia affects distributed circuitry throughout the brain
Слайд 50

The fMR Blood Flow Signal

The fMR Blood Flow Signal

Слайд 51

Verbal Fluency Patients Controls

Verbal Fluency

Patients

Controls

Слайд 52

The N-Back Task for fMR Probe x x Target Experimental Task

The N-Back Task for fMR

Probe

x

x

Target

Experimental Task (2-Back): Remember the Probe and

Monitor for It

Comparison Task: Look for the S

S

A

B

C

D

E

Target

L

G

K

A

Look for the S

2-Back Task

Слайд 53

2-Back Task in Normals Bilateral dorsolateral frontal Bilateral parietal Anterior cingulate

2-Back Task in Normals

Bilateral dorsolateral frontal
Bilateral parietal
Anterior cingulate

Слайд 54

2-Back Task in Schizophrenia (unmedicated) Blood flow markedly decreased or absent

2-Back Task in Schizophrenia (unmedicated)

Blood flow markedly decreased or absent in

regions used by normals
Main activation is anterior cingulate
Слайд 55

Sensory Gating A problem in filtering or gating information Leads to

Sensory Gating

A problem in filtering or gating information
Leads to the subject

experience of being bombarded by stimuli
Explains most symptoms—e.g., confusion of internal and external stimuli would cause delusions and hallucinations
Supported by neurophysiological studies of prepulse inhibition
Слайд 56

Cognitive Dysmetria A defect in coordinating mental activity Due to disturbed

Cognitive Dysmetria

A defect in coordinating mental activity
Due to disturbed functional connectivity

between the cortex and subcortical regions (thalamus and cerebellum)
Leads to functional and cognitive misconnections
Explains diversity of symptoms (e.g., misconnecting a perception and its meaning might lead to delusions and hallucinations)
Supported by functional imaging studies
Слайд 57

Слайд 58

Simplified Summary of Various Anatomical Refinements of the Dopamine Hypotheses of

Simplified Summary of Various Anatomical Refinements of the Dopamine Hypotheses of

Schizophrenia

Laruelle, Biol psychiatry 2013;74:80–81

AST, associative striatum; DA, dopamine; DLPFC, dorsolateral prefrontal cortex; VST, ventral striatum

Слайд 59

Copyright restrictions may apply. Howes, O. D. et al. Arch Gen

Copyright restrictions may apply.

Howes, O. D. et al. Arch Gen Psychiatry

2012;0:archgenpsychiatry.2012.169v1-11.

Schematic diagram summarizing the findings from our meta-analyses of dopamine function in schizophrenia

Слайд 60

Multiple hits interact to result in (1) striatal dopamine dysregulation to

Multiple hits interact to result in (1) striatal dopamine dysregulation to

alter (2) the appraisal of stimuli and resulting in psychosis, whilst current antipsychotic drugs (3) act downstream of the primary dopaminergic dysregulation.
Слайд 61


Слайд 62

Слайд 63

The Essence of Schizophrenia Originally called “dementia praecox” Produces severe incapacity

The Essence of Schizophrenia

Originally called “dementia praecox”
Produces severe incapacity – “dementia”
Typically

begins in adolescence – “praecox”
Слайд 64

Kraepelin: Course and Outcome Split “dementia praecox” from manic-depressive illness Early

Kraepelin: Course and Outcome

Split “dementia praecox” from manic-depressive illness
Early onset
Marked deterioration
Chronic

course
Diversity of signs and symptoms
Importance of volition and affect
Слайд 65

Fundamental Questions about Schizophrenia What are the characteristic symptoms? What are

Fundamental Questions about Schizophrenia

What are the characteristic symptoms?
What are the boundaries

of the concept?
Is the disorder a single illness or multiple disorders?
If multiple, what are the subtypes?
Слайд 66

Lifetime Prevalence What proportion of the population will develop the disorder

Lifetime Prevalence

What proportion of the population will develop the disorder at

some time during their lifetime?
Perhaps the most important statistic for schizophrenia because of its inherent chronicity
Prevalence 0.30-0.66% - narrow diagnostic category of schizophrenia
Prevalence 2.3% - schizophrenia and related psychoses (e.g., delusional, catch-all category of NOS)
Prevalence 3.5% - broader category of psychotic disorders including schizophrenia and related disorders, substance-induced psychotic disorders and bipolar disorder
Слайд 67

Слайд 68

Слайд 69

Слайд 70

Слайд 71

Слайд 72